The additional funds reflect MedManage’s solid revenue growth stemming from its flagship product, eMedSample a drug sample voucher program, which assists pharmaceutical manufacturers in generating prescriptions for new drug products.
The financing was led by MedManage’s lead venture capital investors, which include Prism Venture Partners, Tredegar Investments and additional private investors.
The funds raised from this financing, coupled with the consistent development of strategic partnerships with significant players in the pharmaceutical and healthcare industries, paves the way for a solid path to profitability and reflects confidence in our innovative alternative sampling program for pharmaceutical manufacturers and healthcare organizations, said Zachary Hector, president and CEO of MedManage Systems, in a statement to the press. We will use these funds to further develop eMedSample and market it to a growing number of pharmaceutical and healthcare organizations who are seeking improved mechanisms for drug product sampling.
